INTERNATIONAL PATENT: EPIGENIC THERAPEUTICS, INC., 益杰立科（上海）生物科技有限公司 FILES APPLICATION FOR "METHOD FOR TARGETED REGULATION OF PCSK9 BY MEANS OF EPIGENETIC EDITING AND USE THEREOF"

Posted On: 2025-12-29

GENEVA, Dec. 29 -- EPIGENIC THERAPEUTICS, INC. (Floor 5&6,Unit 1,Building 4,No. 160 Basheng Road,China(Shanghai)Pilot Free Trade ZonePudong New Area, Shanghai 200131), 益杰立科（上海）生物科技有限公司 (中国上海市浦东新区中国（上海）自由贸易试验区巴圣路160号4号楼1单元5层&6层) filed a patent application (PCT/CN2025/102437) for "METHOD FOR TARGETED REGULATION OF PCSK9 BY MEANS OF EPIGENETIC EDITING AND USE THEREOF" on Jun 20, 2025. With publication no. WO/2025/...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

INTERNATIONAL PATENT: EPIGENIC THERAPEUTICS, INC., 益杰立科（上海）生物科技有限公司 FILES APPLICATION FOR "METHOD FOR TARGETED REGULATION OF PCSK9 BY MEANS OF EPIGENETIC EDITING AND USE THEREOF"